Humira
NDC Package 0074-9374-71

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Humira is adalimumab is used to reduce pain and swelling due to certain types of arthritis (such as rheumatoid, psoriatic, juvenile idiopathic, ankylosing spondylitis). Marketed by Abbvie Inc., this product is identified by NDC 0074-9374 and is authorized under FDA application BLA125057.

Identification & Billing

NDC Package Code
0074-9374-71
Package Description
2 KIT in 1 CARTON / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE * 1 mL in 1 PACKET
Product Code
0074-9374
11-Digit Billing Format
00074937471
RxNorm Crosswalk
  • RxCUI: 1594352 - {6 (0.8 ML adalimumab 50 MG/ML Prefilled Syringe [Humira]) } Pack [Humira Pediatric Crohn's Disease Starter Package (6 count)]
  • RxCUI: 1594352 - Humira Pediatric Crohn's Disease Starter Package (6 count)
  • RxCUI: 1594352 - Humira Pediatric Crohn's Disease Starter Pack 40 MG/0.8 ML Prefilled Syringe (6 count)
  • RxCUI: 1594357 - {3 (0.8 ML adalimumab 50 MG/ML Prefilled Syringe) } Pack
  • RxCUI: 1594357 - adalimumab pediatric starter pack 40 MG/0.8 ML Prefilled Syringe (3 count)

Clinical Specifications

Proprietary Name
Humira
Dosage Form
-
Usage Information
Adalimumab is used to reduce pain and swelling due to certain types of arthritis (such as rheumatoid, psoriatic, juvenile idiopathic, ankylosing spondylitis). This medication is also used to treat certain skin disorders (such as plaque-type psoriasis, hidradenitis suppurativa). It works by blocking a protein (tumor necrosis factor or TNF) found in the body's immune system that causes joint swelling and damage in arthritis as well as red scaly patches in psoriasis. Adalimumab belongs to a class of drugs known as TNF blockers. By reducing joint swelling, this medication helps to reduce further joint damage and preserve joint function. Adalimumab is also used to treat certain bowel conditions (Crohn's disease, ulcerative colitis) and a certain eye disease (uveitis).

Regulatory & Marketing

Labeler Name
Abbvie Inc.
FDA Application #
BLA125057
Marketing Category
BLA - A product marketed under an approved Biologic License Application.
Start Marketing Date
02-21-2008
End Marketing Date
01-31-2021
Listing Expiration
01-31-2021
Exclude Flag
D
Sample Package
Yes

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0074-9374-71 identifies a specific commercial package of 2 kit in 1 carton / 1 kit in 1 kit * 1 syringe in 1 tray / .4 ml in 1 syringe * 1 ml in 1 packet of Humira, labeled by Abbvie Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Abbvie Inc. on February 21, 2008. The current certification is valid through January 31, 2021.

What are the primary indications for this medication?

Adalimumab is used to reduce pain and swelling due to certain types of arthritis (such as rheumatoid, psoriatic, juvenile idiopathic, ankylosing spondylitis). This medication is also used to treat certain skin disorders (such as plaque-type psoriasis, hidradenitis suppurativa). It works by blocking a protein (tumor necrosis factor or TNF) found in the body's immune system that causes joint swelling and damage in arthritis as well as red scaly patches in psoriasis. Adalimumab belongs to a class of drugs known as TNF blockers. By reducing joint swelling, this medication helps to reduce further joint damage and preserve joint function. Adalimumab is also used to treat certain bowel conditions (Crohn's disease, ulcerative colitis) and a certain eye disease (uveitis).

How is this Abbvie Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00074937471. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0074-9374-71
11-Digit CMS (5-4-2)
00074-9374-71

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.